Back to Search
Start Over
A trial of topiramate for patients with hereditary spinocerebellar ataxia
- Source :
- Clinical Case Reports, Vol 11, Iss 2, Pp n/a-n/a (2023)
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
-
Abstract
- Abstract In an open pilot trial, six patients with various hereditary forms of spinocerebellar ataxia (SCA) were assigned to topiramate (50 mg/day) for 24 weeks. Four patients completed the protocol without adverse events. Of these four patients, topiramate was effective for three patients. Some patients with SCA could respond to treatment with topiramate.
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 11
- Issue :
- 2
- Database :
- Directory of Open Access Journals
- Journal :
- Clinical Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.7953f2e0edcf41089893dae70717983a
- Document Type :
- article
- Full Text :
- https://doi.org/10.1002/ccr3.6980